Skip to content

The effects of metformin add-on insulin on glycemic control in type 2 diabetic patients with cirrhosis

management of glycemic control in type 2 diabetic patients with cirrhosis

Status
Recruiting
Phases
Phase 4
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000030133
Enrollment
Unknown
Registered
2020-02-24
Start date
2019-01-01
Completion date
Unknown
Last updated
2020-02-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 2 diabetes

Interventions

Case series:metformin add-on insulin

Sponsors

Jingjiang People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. patients aged >18 and <80 years; 2. confirmed T2D with history or HbA1c 6.5%; 3. body mass index (BMI) 21 to 35 kg/m2.

Exclusion criteria

Exclusion criteria: Patients were excluded if they had a randomized blood glucose concentration >200 mg/dL, chronic kidney disease, or were unwilling to participate in this study.

Design outcomes

Primary

MeasureTime frame
MAGE;SD;CV;TIR;

Countries

China

Contacts

Public ContactLiu Yang

Jingjiang People's Hospital

yangliu1905@163.com+86 13815940080

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026